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Toxoplasmosis is a zoonosis distributed all over the world, which the etiologic agent
is an intracellular protozoan parasite, Toxoplasma gondii. This disease may cause
abortions and severe diseases in many warm-blood hosts, including humans, particularly
the immunocompromised patients. The parasite specialized secretory organelles, as
micronemes, rhoptries and dense granules, are critical for the successful parasitism.
The dense granule protein 2 (GRA2) is a parasite immunogenic protein secreted during
infections and previous studies have been shown that this parasite component is crucial
for the formation of intravacuolar membranous nanotubular network (MNN), as well
as for secretion into the vacuole and spatial organization of the parasites within the
vacuole. In the present study, we produced a monoclonal antibody to GRA2 (C3C5
mAb, isotype IgG2b), mapped the immunodominant epitope of the protein by phage
display and built GRA2 synthetic epitopes to evaluate their ability to protect mice in a
model of experimental infection. Our results showed that synthetic peptides for B- and
T-cell epitopes are able to improve survival of immunized animals. In contrast with
non-immunized animals, the immunized mice with both B- and T-cell epitopes had a
better balance of cytokines and demonstrated higher levels of IL-10, IL-4 and IL-17
production, though similar levels of TNF-α and IL-6 were observed. The immunization
with both B- and T-cell epitopes resulted in survival rate higher than 85%of the challenged
mice. Overall, these results demonstrate that immunization with synthetic epitopes for
both B- and T-cells from GRA2 protein can be more effective to protect against infection
by T. gondii.
Keywords: Toxoplasma gondii, GRA2, monoclonal antibody, B- and T-cell epitopes
Abbreviations: GRA, dense granules proteins; PV, parasitophorous vacuole; STAg, soluble tachyzoite antigen; ME,
mercaptoethanol.
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INTRODUCTION
Toxoplasmosis is a congenital or acquired infectious disease
caused by Toxoplasma gondii, an obligate intracellular protozoan
(Dubey, 2010). It is an important cause of neonatal disorders and
opportunistic infections in animals and humans (Montoya and
Liesenfeld, 2004).
Toxoplasma gondii has regulated secretory organelles involved
in invasion and replication strategies, which include the apical
micronemes and rhoptries, as well as the dense granules (Black
and Boothroyd, 2000; Franco et al., 2016).
Host cell invasion by T. gondii tachyzoites has been described
as process involving the sequential secretion of micronemes
and rhoptry proteins (Carruthers and Sibley, 1997). Successful
intracellular development is based by active invasion process
and formation of a new sub-cellular compartment named the
parasitophorous vacuole (PV) (Braun et al., 2008). The dense
granules (GRA) proteins are secreted into the PV during invasion
in the host cell and remain soluble in the PV lumen or associated
with PVmembrane (PVM) or tubulovesicular network (TVN) of
membranous structure within the PV (Zinecker et al., 1998; Nam,
2009).
Several studies have been conducted with GRA proteins and
related with host-parasite interaction and immune response
(Sibley et al., 1995; Mercier et al., 1998a; Xue et al., 2008; Zhou
et al., 2012). GRA2 can be detected during infections in humans
and domestic animals and in experimental models, showing its
potential immunogenic capability (Murray et al., 1993; Xue et al.,
2008). The GRA2 protein can induce a long-term activation
of T helper cell-T. gondii specific in humans (Prigione et al.,
2000). This immunological response to GRA2 may be important
to control infection and immunization studies with the native
protein have been shown to elicit protection in mice with acute
toxoplasmosis (Sharma et al., 1984; Mercier et al., 1998b).
In order to better understand the role of GRA2 in the adaptive
immune responses against T. gondii, the major aim of the present
study was to map B- and T- cell epitopes by phage display and
epitope prediction and to test the ability of two selected linear
peptides to protect mice in an experimental model of infection
by T. gondii.
MATERIALS AND METHODS
Parasites and Soluble Tachyzoite Antigen
(STAg)
Tachyzoites from RH strain of T. gondii, as well as the 2F1
parasite clone used for proliferation assay, were obtained as
previously described (Mineo et al., 1993; Teo et al., 2007). Parasite
suspensions were washed in PBS, added a protease inhibitor
cocktail (Complete Ultra tablets, Roche, USA), and processed for
lysis by repeated freezing and thawing cycles, followed by three
cycles in cell disruptor for 1 min in ice bath. The preparations
were centrifuged at 14,000× g for 30min at 4◦C. After discarding
the sediment, the protein concentration in supernatant was
determined by the Bicinchoninic acid kit (BCA, Sigma, St. Louis,
USA) and aliquots were stored as soluble tachyzoite antigen
(STAg) at−80◦C until use.
Production of Monoclonal Antibodies
Freshly harvested T. gondii RH strain tachyzoites were treated
with acetone solution (30%), at 4◦C for 72 h. Parasite suspensions
were washed in PBS and used for immunization of Balb/c
mice. Hybridoma production was performed as previously
described (Cunha-Júnior et al., 2010). Briefly, hybridomas were
produced by fusion of splenocytes extracted from immunized
mice with SP2O/Ag14murinemyeloma cells (1:1) in the presence
of polyethyleneglycol (PEG1500; Sigma-Aldrich) and specific
secreting hybridomas were selected by ELISA. The hybridoma
(C3C5) selected was cloned by limiting dilution, and isotyped by
immunoenzymatic assay (IsoQuickTM, Sigma-Aldrich).
Indirect Fluorescent Antibody Test (IFAT)
The indirect immunofluorescence assay was performed for
immunolocalization of the protein tagged by C3C5 mAb
against T. gondii tachyzoites, as previously described (Ferreira
Júnior et al., 2012), with minor modifications. Briefly, parasites
were treated with 4% formaldehyde, during 30 min, at room
temperature, washed in PBS and placed on glass slides, where
they were permeabilized by Triton X-100 0.1% for 10 min
at room temperature, and incubated with C3C5 mAb. After
washing, slides were incubated with rabbit IgG anti-mouse IgG
labeled with fluorescein isothiocyanate (FITC; Sigma). Slides
were then analyzed by confocal microscope (LM 510 Meta, Zeiss,
Germany). Positive and negative serum samples controls were
included in each slide and they were obtained from chronically
infected and naive Balb/c mice, respectively.
1D- and 2D-Immunoblot Assays
Immunoblot assays were carried out to characterize the protein
recognized by C3C5 mAb. In 1D-immunoblot, STAg was
separated on 12% SDS-PAGE under non-reducing conditions
and electrotransferred to nitrocellulose membranes, which were
blocked by 5% skim milk-PBS-T. Nitrocellulose strips were
then incubated with C3C5 overnight at 4◦C. The secondary
antibody, consisting of mouse anti-IgG labeled with peroxidase
(Sigma-Aldrich), diluted at 1:2000, was added to strips for 2
h at room temperature. Reactions were revealed with 10mg of
3,3- diaminobenzidine tetrahydrochloride (DAB, Sigma-Aldrich)
in 15 mL of Tris buffered saline (TBS) and 12 µL of 30%
hydrogen peroxide (Sigma-Aldrich) and stopped with several
washes in distilled water. A 2D-immunoblot assay was also
carried out to evaluate the recognition of STAg protein by
C3C5 mAb. Briefly, 0.5mg of STAg dialyzed in ultrapure
water was separated by isoelectric focusing (IEF) on 11-cm
immobilized pH gradient strips (ReadyStripTM IPG Strip pH 3–
10) overnight at room temperature, according to manufacturer
instructions for equipment and reagents (GE Healthcare,
Uppsala, Sweden). After IEF, strips were equilibrated and
loaded onto precast 12% polyacrylamide gels. Electrophoresis
was performed and 2D-gels were stained with Coomassie
brilliant blue G-250H (Sigma-Aldrich) or electrotransferred
to nitrocellulose membranes. 2D-immunoblot was performed
as described above for 1D-immunoblot. Positive reactions
were detected by chemiluminescence (ECL, GE Biosciences
Amersham, Piscataway, USA). The corresponding spots were
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excised from the Comassie brilliant blue stained gel and
submitted for analysis by mass spectrometry.
In-Gel Trypsin Digestion and Mass
Spectrometry
The identification of protein by mass spectrometry was
performed as described elsewhere (Shevchenko et al., 1996). The
spots of interest were selected and excised manually from 2D gels
previously stained with Coomassie brilliant blue. Gel pieces were
washed with 25 mM ammonium bicarbonate and 50% ACN,
dried by vacuum centrifugation and subsequently treated with
5–7 µg/mL of trypsin (Promega, Madison, USA) according to
the manufacturer instructions. The resulting tryptic digests were
vacuum concentrated, desalted using a preymmetry column C18
(180 µm in inner diameter × 20 mm long, 5 µm particles) and
then fractioned by a C18 reverse phase chromatography column
(100µm× 100mm, 1.7µm) on the nanoAcquity UPLC (Waters,
Mildford, USA), with load flow of 0.6 µL/min by 50 min/run.
Each sample was collected for posterior analysis. The peptides
were separated in accordance with gradient steps of water/ACN.
The separated peptides were ionized in a capillary under voltage
of 3000 V (Micromass Q-Tof MicroTM), fragmented in the
positive ion mode, with selection of the relative intensity of at
least 10 counts, and analyzed the three most intense ions (scan/s)
with collision energy varying between 20 and 95 eV, according
to mass/charge(m/z) of peptides. The spectra were analyzed by
Protein Lynx Global Server (PLGS) 4.2 (Waters) set up to tryptic
digestion with onemissed cleavage site, error tolerance of 30 ppm
and tolerance for error of 0.3 Da mass equal to the peptides were
constructed by the de novo sequencing method, and searched
in the National Center for Biotechnology Information (NCBI)
database.
Peptide Selection from Phage Display
Library
A random peptide library of seven amino acids (Ph.D-C7C, New
England Biolabs, Hitchin, UK) was used for selection of peptides
in fusion with the protein III (pIII) of the filamentous phage
(M13) capsid specific to monoclonal antibody C3C5. One well of
a microtiter plate (96-well Maxisorp plate, Nunc, Sigma-Aldrich)
was coated with C3C5 mAb (1 µg/well in NaHCO3 0.1 M, pH
8.6), and incubated overnight 4◦C in a humidified chamber. The
reaction was blocked with blocking buffer (NaHCO3 0.1 M, pH
8.6, 5 mg/mL BSA) for 1 h under agitation at 4◦C and then
washed six times with TBST (50 Tris-HCl mM pH 7.5, NaCl
150mM, water, 0.1% volume/volume of Tween 20). Immediately,
10 µL of the library diluted in 90 µL of TBST were added
and kept under agitation for 1 h at room temperature. Non-
ligand phages were removed by washing 10 times with TBST
(0.1% Tween-20) in the first two selection cycles and with TBST
(0.5% Tween-20) in the third subsequent cycle to increase the
stringency. Bound phages were eluted in 100 µL of elution buffer
(0.2 M Glicine-HCl, pH 2.2, and BSA 1 mg/mL) during 10 min
at room temperature and the supernatant were neutralized with
1 M Tris-HCl (pH 9.1). Aliquots of the eluted phages were
used for titer determination. Phage titration and amplification
were performed in E. coli (ER2738 strain) and the selection
was repeated for two additional cycles. Resultant clones were
individually reamplified in deep-well plates. These clones were
properly characterized by sequencing and immunoenzymatic
assays. The colonies derived from biopanning titrated plates were
isolated and transferred to wells of culture plates (deepwell type),
containing culture of ER2738 in early-log phase (OD 600 ∼
0.3) for the extraction of DNA phage. The plate was sealed and
incubated at 37◦C for 24 h under agitation (250 rpm). To isolate
phage of bacteria, plates were centrifuged at 3700 rpm at 20◦C for
30 min. Next, supernatant incubated for 10 min with PEG/NaCl
(20% polyethylene glycol 8000 and 2.5 M NaCl). The plates were
centrifuged at 3700 rpm at 20◦C for 40 min to precipitate the
phage. The supernatant was discarded and 100 µL of iodide
buffer (10 mMTris-HCl pH 8.0, 1 mMEDTA, and 4MNaI) were
added to precipitate phage. After being shaken vigorously for 40 s
and incubation at room temperature, the plates were centrifuged
(3700 rpm, 20◦C, 10 min) and the supernatant discarded. The
phage DNA was washed with ethanol 70% and centrifuged under
the same conditions. Finally, the DNA precipitated was diluted
in Milli-Q water. The single stranded DNA quality was verified
by electrophoretic run on 0.8% agarose gel stained with ethidium
bromide solution.
Analysis and Characterization of Clones
Selected phages were submitted to DNA sequencing, which
was carried out by using the “Big Dye Terminator” sequencing
kit (GE Healthcare), and the universal “primer” (96 M13- 5′-
HOCCCTCATTAGTTAGCGCGTAACG 3′–GE Healthcare)
to amplify the recombinant amino acids region coded by
random peptides fused at the pIII of the M13 phage in the
automatic capillary sequencer MegaBace 1000 (GE Healthcare).
DNA sequences were then submitted to bioinformatics
analyses. Amino acid sequences were deduced according to
the nucleotide sequences and analyzed using the translate
tool from ExPASy—SIB Bioinformatics Resource Portal
(http://web.expasy.org/translate/).
Bioinformatics
The three-dimensional structure predictions of the GRA2
protein were performed with the I-TASSER server (Roy
et al., 2010). The similarity of selected peptides with GRA2
T. gondii was performed using BLAST search (Basic Local
Aligment Search Tool) (http://www.ncbi.nlm.nih.gov/blast),
followed by sequence alignment with ClustalW2 software
(http://www.ebi.ac.uk/Tools/msa/clustalw2/). The similarities
between selected peptides and proteins deposited were
performed using the tool BLAST. Predicted epitopes to T
cell and B cell for the protein GRA2 were obtained in Immune
Epitope Database and Analysis Resource (http://iedb.org/).
Peptide Design and Synthesis
Two peptide sequences from GRA2 were designed and
chemically synthesized by Peptide 2.0 Inc. (Chantilly, USA).
To increase immunogenicity, peptides were coupled to bovine
serum albumin (BSA). The peptide Tx1 (ACEPVSQRASCGGGS)
was constructed with 15 residues and peptide Tx2
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FIGURE 1 | Selection and immunochemical characterization of monoclonal antibody C3C5 specific for GRA2 protein of Toxoplasma gondii. (A)
Isotyping of C3C5 mAb by using an immunoenzymatic assay in culture supernatant. (B) 1D immunoblot of T. gondii RH strain tachyzoites solubilized in SDS sample
buffer and resolved in 12% SDS-PAGE and probed with no infected mouse serum sample (Lane 1), T. gondii infected mouse serum sample (Lane 2), C3C5 mAb
(Lane 3), and anti-p30 mAb E9 (Lane 4). (C) 2D immunoblot of T. gondii RH strain tachyzoites solubilized in isoelectric focalization solution and resolved through pH
3–10 and then in 12% SDS-PAGE. After electrotransference to nitrocellulose membranes, antigens were probed with C3C5 mAb. (D) Indirect fluorescent antibody
test (IFAT) of T. gondii RH strain probed with mice serum no infected (−), infected with T. gondii (+) and monoclonal antibody C3C5. Slides containing parasite were
permeabilized (+) or not (−) with Triton X-100 0.01% for 10 min. (E) Proliferation inhibition of T. gondii infection by C3C5 mAb in HeLa. T. gondii 2F1 strain tachyzoites
were pretreated for 60 min at 37◦C, 5% CO2 with increased concentration (1.56–100 µg/mL) of C3C5 mAb and irrelevant mouse IgG. The proliferation assay was
development from β–gal activity measured at absorbance of 550 nm using a kinetic plate reader (Molecular Devices).
(RASRVAEQLFRKFLKFAGGGS) was constructed with 21
residues, both containing a 4-aa spacer, GGGS. Three glycines
(G) and amidation C-terminal disulfide bond between amino
acids 2 and 11 were added in Tx1 peptide sequence. Tx2 peptide
possessed the sequence of glycine and C-terminal amidation
only. The peptides were lyophilized and later solubilized in
Dimethylsulfoxide (DMSO-Sigma).
Immunization Procedure
All experiments were carried out with 6–10 week-old female
C57BL/6 mice obtained from Department of Biochemistry
and Immunology, School of Medicine of Ribeirão Preto, USP,
Ribeirão Preto, Brazil. Animals were maintained under standard
conditions in the Bioterism Center and Animal Experimentation,
Federal University of Uberlandia, Brazil. All procedures were
conducted according to institutional guidelines for animal ethics
and the study received approval of the Ethics Committee
for Animal Experimentation of the Institution (CEUA-UFU),
under the protocol # 029/12. Five groups of 10 mice were
immunized subcutaneously with the following formulations:
25 µg of STAg (STAg group), Tx1 (Tx1 group), Tx2 (Tx2
group), Tx1 plus Tx2 (Tx1+Tx2 group), or BSA (BSA group)
in 100 µL of sterile PBS added to 100 µL Freund’s adjuvant
(Sigma) (STAg group). Immunizations were carried out at
regular intervals of 15 days in three successive inoculations.
The first immunization was performed with Freund’s complete
adjuvant and the two remaining with incomplete Freund’s
adjuvant. Blood samples were collected at 0, 15, 30, 45 days
after immunization (d.a.i) and the sera analyzed for the presence
of specific antibodies. Two weeks after the last immunization
(45 d.a.i.), seven animals per group were challenged orally
with 30 cysts of T. gondii (ME49 strain). All surviving animals
were euthanized at 30 days after challenge (75 d.a.i.), the
brain tissues were collected, sliced longitudinally and stored
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FIGURE 2 | Epitope mapping of GRA2 by Phage Display and peptides synthesis. (A) Peptide sequences of 24 phage clones and their consensus sequences,
according to the original sequence determined for the C-terminal region of the GRA2 protein. (B) Immunodominant region especially for B cell (http://iedb.org/). (C)
Based on the results of prediction for B cells and T cells into GRA2 structure was designed to be synthesized two peptides, Tx1 and Tx2, respectively.
at −70◦C for quantification of parasite burden by real-time
PCR.
Indirect ELISA for Detection of Antibodies
Anti-STAg and Anti-Peptides
The kinetics of IgG produced by the immunized mice was
evaluated by an indirect ELISA. The optimal conditions
for ELISA were obtained through block titration of the
reagents. Briefly, high affinity microtiter plates (Costar Corning
Incorporated, Sigma-Aldrich) were coated with STAg (10
µg/mL) and the peptide mixed (Tx1+Tx2) (1 µg/well) in
0.06 M carbonate buffer (pH 9.6) and incubated overnight
at 4◦C. Plates were washed with PBS-Tween 0.05% (PBS-T)
and blocked with PBS-T plus 1% low fat milk for 1 h at
room temperature. Serum samples from immunized mice with
BSA, STAg and Tx1+Tx2 were added to the wells in duplicate
and incubated for 1 h at 37◦C. After washing, plates were
incubated with anti-mouse IgG antibody labeled with peroxidase,
diluted 1:2000 in PBS-T, for 1 h at 37◦C. The reactions were
revealed by adding 0.01M 2,29-azino-bis(3-ethylbenzthiazoline-
6-sulphonic acid) (ABTS, Sigma-Aldrich) and 0.03% H2O2.The
optical density (OD) was determined at 405 nm. Four positive
quality-controls and four negative controls (serum from non-
immunized animals and uninfected) were included in each plate
in order to calculate the cut off, which was established as themean
OD values for negative controls plus three standard deviations.
A similar protocol was applied to detect IgG subclasses, IgG1
and IgG2a). After washing with primary antibody, plates were
incubated with biotinylated secondary antibodies (Caltag Lab.
Inc., South San Francisco, USA) anti-IgG1 mouse diluted
1:4000 with PBS-T 1% or anti-IgG 2a mouse diluted 1:2000.
After incubation for 1 h at 37◦C, the plates were washed
again and incubated (50 µL/well) with streptavidin-peroxidase
(Sigma-Aldrich) diluted 1:1000 in PBS-1% BSA T. Results
were expressed as ELISA index (EI), as previously described
(Silva et al., 2002), according to the following formula: EI =
ODsample/ODcut−off, where values of EI > 1.2 were considered
positive.
Cytokine Quantification
Cytokine analysis was performed in serum samples from
immunized animals and infected with T. gondii. The serum
samples were collected after 7 days of infection. The dosage
of cytokine in these sera was done using the CBA kit
(Cytometric Bead Array—BD Biosciences, Franklin Lakes, USA).
The reactions were performed according to the manufacturer’s
instructions and the analysis was performed on the flow
cytometer from BD FACS Canto II.
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FIGURE 3 | Structural modeling of dense granule 2 (GRA2) of
Toxoplasma gondii. In silico analysis of three-dimensional structure of GRA2
protein were performed to search for possible intrinsically unstructured protein
(IUP) domains, evidencing predicted epitopes for B (highlighted in yellow) and
T (highlighted in red).
Detection of Parasite Burden by
Quantitative Real-Time PCR
Parasite burden in the brains of mice was determined by
quantitative real-time PCR, as previously described (Wahab
et al., 2010), using primer pairs (5′-GCTCCTCCAGCCGTC
TTG-3′ and the reverse primer 5′-TCCTCACCCTCGCCT
TCAT-3′) targeting the repetitive 529 bp fragment of T. gondii
genomic DNA, by SYBR green detection system (Invitrogen, San
Francisco, USA). DNA extraction was performed from murine
brain tissues using the Wizard SV Genomic DNA kit (Promega)
following manufacturer’s instructions. DNA concentrations were
determined by UV spectrophotometry at 260 nm (NanoDrop R©
Spectrophotometer 1800 ND-1000, NanoDrop Technologies,
Inc, Wilmington, USA) and adjusted to 200 ng/µL with sterile
DNAse free water. Assays to determine T. gondii tachyzoite loads
were performed by real-time PCR StepOnePlusTM PCR Systems
(Applied Biosystems, Foster City, USA). The reaction mixtures
(25 µL) consisted of 1 µL TaqMan PCR master mix (Applied
Biosystems), 100 nM probe, and 900 nM (each) primers, forward
and reverse, together with the different samples in triplicate.
The amplification conditions comprised 50◦C for 2 min, initial
activation at 95◦C for 10 min, and 45 cycles of denaturation at
95◦C for 15 s and annealing/extension at 60◦C for 1 min. The
parasite counts were calculated by interpolation from a standard
curve (102–10−7 ng) with DNA equivalents extracted from T.
gondii tachyzoites included in each run.
Statistical Analysis
Statistical analysis was carried out using GraphPad Prism
5.0 (GraphPad Software Inc., San Diego, USA). Differences
between groups were analyzed using ANOVA or Kruskal-
Wallis test, when appropriate, followed by Bonferroni or Dunn
multiple comparison post-tests to examine all possible pairwise
comparisons. Student t-test was used for comparison between
levels of IgG1 and IgG2a isotypes. The Kaplan-Meier method was
applied to estimate the survival percentage of mice at each time
point after challenge and survival curves were compared using
the Log-rank test. Values of P < 0.05 were considered statistically
significant.
RESULTS
Characterization of C3C5 Monoclonal
Antibody
The C3C5 mAb was characterized as belonging to the isotype
IgG2b (Figure 1A). To identify the type of epitope recognized
by C3C5 mAb, 1D immunoblot was carried out with SDS-
soluble antigen in the presence or absence of 2 mercaptoethanol
(Figure 1B). The C3C5 mAb recognized a polypeptide of about
45 kDa in non-reducing denaturing condition, whereas this
polypeptide could not be visualized when reducing denaturing
condition was performed. In contrast, the profile of reactivity for
the E9 mAb used as control recognizes an epitope from 30 kDa
protein (p30) of T. gondii in both conditions (Figure 1B).
To identify the presence of proteins that could be recognized
by C3C5 mAb, a 2D immunoblot assay was carried out
(Figure 1C). Two spots migrating at 45 kDa were detected,
indicating that at least two isoforms of protein contained
common epitope recognized by C3C5 mAb. The cellular
localization of epitopes in T. gondii tachyzoites were examined by
immunofluorescence (Figure 1D). Slides incubated with serum
from infected animals (positive control), uninfected animal
(negative control), and C3C5 mAb were observed by confocal
microscopy. C3C5 mAb recognized tachyzoites permeabilized or
not, however higher stained can be observed in permeabilized.
The proliferation inhibition of T. gondii (2F1 strain) was
observed by C3C5 mAb (Figure 1E). The highest inhibition
profile was obtained with 100 µg/mL of C3C5 mAb, when
compared to incubation with the same amount of isotype control.
Epitope Mapping by Phage Display and
Peptide Synthesis
Twenty-four randomly selected mimotopes were obtained after
three rounds of biopanning using a phage displayed 7-
mer random peptide library against C3C5 mAb (Figure 2A).
Alignment analysis revealed the consensus sequence comprised
between amino acids 68–76 of protein GRA2 of T. gondii and
revealed be an immunodominant region for B cell (highlighted
in Figure 2B). In silico prediction shows that MHCI/MHCII
epitopes can be found within the same region of the B cell
epitope. In that sense, we synthesized two peptides, one for B cell
(Tx1) and another for T cell (Tx2) to be used in immunization
protocols (Figure 2C).
Protein Modeling
To confirm the surface exposure probability of the consensus
amino acids sequence, we have performed a simulation to
generate a 3D structure of the GRA2 protein. The putative
localization of the epitope within the structure was shown
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FIGURE 4 | Survival curves of C57BL/6 mice after challenge with Toxoplasma gondii. Five groups of mice (10 animals per group) were immunized with soluble
tachyzoite antigen (STAg); bovine serum albumin (BSA); synthetic peptide Tx1 (Tx1); synthetic peptide Tx2 (Tx2) and both synthetic peptides (Tx1+Tx2). All curves are
compared to the group immunized only with BSA. (A) Survival of the BSA group (28.6%) and survival group STAg (71.4%). (B) Survival of the BSA group (28.6%) and
survival group Tx1 (42.8 %). (C) Survival of the BSA group (28.6%) and survival group Tx2 (71.4 %). (D) Survival of the BSA group (28.6%) and survival group
Tx1+Tx2 (85.7%). This group showed significant difference in survival. *P < 0.05.
FIGURE 5 | Levels of IgG, IgG1, and IgG2a anti-STAg (A) or anti-Tx1+Tx2 (B) determined by ELISA in serum samples from C57BL/6 mice immunized
with STAg, BSA or Tx1+Tx2. It was observed that animals immunized with STAg recognized only STAg and animals immunized with Tx1+Tx2 only recognized
Tx1+Tx2.
in Figure 3, corroborating with the possible antibody binding
region in the external sequences of the predicted protein.
Survival of Immunized and Challenged
Animals
Two weeks after the last immunization (45 d.a.i.), animals were
challenged orally with 30 cysts of T. gondii tachyzoites and were
monitored for 30 days for the evaluation of mortality. After 30
days of challenge, the higher survival rates were found for the
group immunized with Tx1+Tx2 (85.7%), when compared with
BSA group (28.6%; P < 0.05; Figure 4). To present the best
protection profile of animal challenged with T. gondii, the next
experimental conditions were carried out only with the group of
animals immunized with Tx1+Tx2.
Humoral Immune Response After
Immunization
The profile IgG synthesis and its subclasses anti-STAg and anti-
Tx1+Tx2 production was evaluated by an indirect ELISA. As
shown in Figures 5A,B, high titers of antibodies were detected
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FIGURE 6 | Cytokine production by mice immunized with STAg, BSA, or Tx1+Tx2 after challenge with T. gondii. (A–D) Pro-inflammatory cytokine profiles.
(E,F) Anti-inflammatory cytokine profile. (G) IL-17 production. The group immunized with Tx1+Tx2 presented a better balance between pro- and anti-inflammatory
cytokines.
in immunized animals. Indeed, animals immunized with STAg
or Tx1+Tx2 recognized only STAg or Tx1+Tx2, respectively.
Higher specific IgG1 levels for STAg were observed when
compared to IgG2a profile (Figure 5A). Similar recognition
profile leading to the synthesis of IgG1 and IgG2a subclasses were
found for the animals immunized with Tx1+Tx2 (Figure 5B).
Cytokine Production After Immunization
and Challenge
Cytokine production was assessed in serum samples collected
7 days after infection from animals immunized and challenged.
High levels of IFN-γ, TNF-α, and IL6, in addition with very low
levels of IL-10 and IL-4 were found in BSA immunized group
of animals (Figures 6A–C,E,F), characterizing a predominant
profile of pro-inflammatory cytokine secretion, due to the
low production of anti-inflammatory cytokines for this control
group of animals. In contrast, the group of animals immunized
with Tx1+Tx2, as well as with STAg, demonstrated a balance
between pro- and anti-inflammatory cytokines, characterized by
the detection of higher levels of IL-10, IL-4, when compared
with control animals, in addition with detectable levels of IFN-
γ, TNF-α, and IL6 (Figures 6A–C,E,F). Also, the challenged
animals from the experimental groups immunized with STAg or
Tx1+Tx2 antigen preparations showed higher levels of IL-2 and
IL-17, respectively (Figures 6D,G).
Parasite Burden in the Brains of the
Immunized and Challenged Animals
Brain parasite burden after challenge was determined by real-
time PCR. As shown in Table 1, no significant differences it was
observed in the cerebral parasitism among the groups of animals
immunized with BSA, Tx1, Tx2, or Tx1+Tx2, though lower levels
of parasitism were found in the group of animals immunized
with STAg. These findings were confirmed by direct cyst count
by optical microscopy in the brains of survived animals.
DISCUSSION
In the present study, we produced a monoclonal antibody to
GRA2 (C3C5), a granule dense protein of T. gondii. Our data
indicate that the C3C5 mAb recognizes a conformational epitope
within the GRA2 protein, since it was recognized under SDS
and heat conditions, but not under more drastic conditions,
when adding a reducing agent during SDS-PAGE running.
The theoretical molecular weight of GRA2 protein is 28 kDa,
however, it has been described that a common feature of the
dense granule proteins is the observed difference between their
theoretical molecular weights and the molecular weights of the
native protein estimated by SDS-PAGE analysis from lysates
tachyzoites (Sibley et al., 1995; Mercier et al., 1998a). In fact,
these differences may be due to post-translational modifications,
such as glycosylation and phosphorylation. Furthermore, the
molecular weight was assumed to electrophoresis in denaturing
conditions and not reduced, so the protein structure is intact
and therefore less migratory. The results of immunofluorescence
assays performed with tachyzoites incubated with C3C5 mAb
showed the presence of the protein mainly when the parasite
membrane had been permeabilized, confirming the location of
GRA2 also in the Inner Membrane Complex (IMC) of the
tachyzoites, as previously demonstrated (Sibley et al., 1995;
Mercier et al., 1998a). In the present study, it was also
observed that the proliferation of T. gondii is inhibited, when
the parasites were incubated with C3C5 mAb before infection
of HeLa cells. Accordingly, it was already demonstrated the
importance of GRA2 in the proliferation of the parasite, since
this protein is involved in the maturation of the parasitophorous
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TABLE 1 | Parasite burden in the brains of the immunized and challenged animals as determined by real-time PCR and by direct cyst count by optical
microscopy in the brains of survived animals.
X
X
X
X
X
X
X
X
Parameter
Immunogen
BSA Tx1 Tx2 Tx1+Tx2 STAg
T. gondii DNA (ng)/brain DNA (100 ng) 0.12 ± 0.04 0.14 ± 0.05 0.18 ± 0.03 0.16 ± 0.05 0.06 ± 0.03
Number of cysts/brain 1617 ± 483 1366 ± 357 1916 ± 378 1475 ± 536 471 ± 353
Cerebral parasitism was evaluated among the groups of C57BL/6 mice immunized with BSA, Tx1, Tx2, or Tx1+Tx2 and STAg.
vacuole (PV), where the parasite replicates (Mercier et al.,
2005).
In the present study, it was carried out the phage display
approach to determine the binding between parasite epitope and
C3C5mAb, through the selection process of high affinity peptides
binding to antibodies, namedmimotopes, as previously described
(Germaschewski and Murray, 1995; Smith and Petrenko, 1997;
Wang and Yu, 2004). This approach has been used to determine
mimotopes used to design vaccines and immunoassays to
various parasitic diseases, such as malaria (Greenwood et al.,
1991; Demangel et al., 1996), Chagas disease (Pitcovsky et al.,
2001) and toxoplasmosis (Berghetto et al., 2003; Cunha-Júnior
et al., 2010). Here, this tool has determined several mimotopes
and, consequently, found that the protein was GRA2. From
this, the mAb-linker peptide and another peptide selected
by bioinformatics were used to proceed the immunization
protocols in the animals. Our results showed that the peptide
synthesized as B cell epitope did not improve survival of the
immunized animals. Similar results were obtained for those
animals immunized with peptide synthesized as T cell epitope,
which did not increase survival significantly. In contrast, when
the immunization process was carried out with both B and
T cells epitopes, it was observed a survival rate higher than
85%, demonstrating that the stimulation of both cell populations
induced an immune response more protective. In fact, although
there was no significant difference in terms of IgG production
to justify this increased survival, the immunization with both B
and T cells epitopes induced a regulatory response, which was
expressed by higher levels of high IL-10 and IL-4 production,
whereas the group of animals immunized with BSA presented
an increased inflammatory response, expressed by high IFN-
γ production. It is already known that a protective immune
response induced to control T. gondii infection requires a mixed
Th1/Th2 response, with Th1 predominance (Neyer et al., 1997;
Kumar et al., 1998; Meira et al., 2014). Based in our results, it can
be hypothesized that the higher protection found for the animals
immunized with Tx1+Tx2 can be explained by the induction of
a protective immune response, expressed by a balance between
stimulatory and regulatory cytokine production. It is well
established in the literature that antibody response by itself is not
thought to be critical during a primary infection with T. gondii,
even though the immunoglobulin synthesis plays a significant
role during the secondary immune response (Innes et al., 2009).
Stimulation of the innate immune system occurs early inT. gondii
infection, because the parasites are able to stimulate macrophages
directly resulting in the production of IL-12, which in turn can
stimulate NK cells to produce IFN-γ (Gazzinelli et al., 1993; Innes
et al., 2009). This early induction of IFN-γ is important to inhibit
tachyzoite proliferation during the early stages of infection by
providing the appropriate cytokine environment during the
priming of the adaptive immune response, which results in
a bias toward a Th1-type pro-inflammatory immune response
(Gazzinelli et al., 1996; Innes et al., 2009). The regulatory
cytokine IL-10 is essential for protection against the potential
immunopathological mechanism caused by a vigorous Th1-
type immune response (Gazzinelli et al., 1996; Innes et al.,
2009).
When using immunocompetent animals, T. gondii
experimental infection results in development of protective
immunity against toxoplasmosis, since the challenge has been
carried out using strains from the same genotype. It is already
well documented in the literature that there are significant
differences in virulence and immune response between the
different genetic types of T. gondii. This phenomenon has been
described among clonal genotypes, as well as among those called
atypical/recombinant strains, as it has been observed by our
group also (Franco et al., 2015; Lopes et al., 2016). Concerning
GRA2 molecule, even though there are 98.4% identity and 98.9%
similarity between type I and type II T. gondii genotypes, three
polymorphisms have been identified, which are located at 95,
166, and 167 AA positions. In the present study, it was design
the Tx1 and Tx2 predicted peptides, which are located in a 100%
conserved region of GRA2 molecule from RH and Me49 T.
gondii genotypes, at 68–76 AA positions. The main reason to
carry out our experiment design, i.e., using a type I strain (RH) to
produce peptide and then challenged immunized mice with the
Me49 type II strain, was because we were interested to observe
both survival rates and parasite burden, expressed by formation
of brain cysts. Thus, it was not possible to challenge the mice
with RH strain, due to the fact that this strain does not form
brain cysts in C57BL/6 mouse genotype, which would die very
rapidly, during the acute phase of the infection, after 7–10 days.
To control toxoplasmosis, the vaccination process has a
high likelihood of success, but the selection of an appropriate
antigen preparation constitutes the major challenge. There is
a commercial vaccine available to protect against Toxoplasma
abortion in sheep and goats, named Ovilis1 Toxovax (Intervet)
(Innes and Vermeulen, 2006). This vaccine contains attenuated
live tachyzoites from the S48 strain, which does not produce
oocysts, but it is unable to prevent vertical transmission
(O’Connel et al., 1988). This vaccine has been licensed for
veterinary use only, because there is no data available so
far, concerning its safety to be used in humans. Therefore,
studies leading to the development of a human vaccine able
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prevent congenital toxoplasmosis have focused in using defined
immunodominant antigens and different delivery strategies
(Innes and Vermeulen, 2006). It has been shown that CD4+
T cell Toxoplasma-specific clones from chronically infected
healthy donors react with both SAG1 and GRA2, supporting the
hypothesis that a combination of these antigens or appropriate
derivative peptides represents suitable candidates for vaccine
development in humans (Prigione et al., 2000). In this context,
stimulation of immune response toward GRA2 peptides may
be important to control infection, as immunization with the
native protein has been shown to protect mice against acute
toxoplasmosis (Sharma et al., 1984; Mercier et al., 1998b).
In conclusion, our results demonstrate that the immunization
protocol using synthetic epitopes from T. gondii GRA2 protein
is able to stimulate both B- and T-cells and can be effective
to protect against the parasite infection, corroborating with the
findings regarding the immunogenicity of GRA2 and confirming
that peptides carrying these features from this protein may be
useful candidates to be taken into account in vaccination design
protocols.
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